3rd Circ. Merges 3 Challenges To Medicare Drug Price Talks
By Ryan Harroff · June 14, 2024, 8:10 PM EDT
The Third Circuit will hear three separate appeals challenging Medicare's drug price negotiations together, according to a new order consolidating cases brought by AstraZeneca, Bristol-Myers Squibb and Janssen Pharmaceuticals in New...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login